Your session is about to expire
← Back to Search
Performance-Based Strategy for Substance Abuse Intervention (SAT2HIV-II Trial)
N/A
Waitlist Available
Led By Bryan R Garner, PhD
Research Sponsored by RTI International
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at the end of month 12
Awards & highlights
SAT2HIV-II Trial Summary
This trial will test if staff are more likely to successfully provide a brief intervention for substance use if they are given a monetary bonus for meeting performance targets.
Who is the study for?
This trial is for adults over the age of 18 who have been diagnosed with HIV and are dealing with substance use disorders or substance abuse.Check my eligibility
What is being tested?
The study tests two strategies to improve substance abuse treatment in HIV care. One includes facilitation, training, feedback, and consultation (FTFC), while the other adds pay-for-performance bonuses (FTFC+PFP).See study design
What are the potential side effects?
Since this trial involves non-medical interventions like training and financial incentives rather than drugs or medical procedures, traditional side effects are not applicable.
SAT2HIV-II Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ assessed at the end of month 12
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed at the end of month 12
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Implementation consistency
Implementation quality
Secondary outcome measures
Days using primary substance
Generalized Anxiety Disorder 7-item (GAD-7)
SAT2HIV-II Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Training, Feedback, Consultation, Facilitation, and P4PExperimental Treatment1 Intervention
An enhanced version of the multilevel implementation strategy
Group II: Training, Feedback, Consultation, and FacilitationActive Control1 Intervention
A multilevel implementation strategy
Find a Location
Who is running the clinical trial?
RTI InternationalLead Sponsor
188 Previous Clinical Trials
875,515 Total Patients Enrolled
6 Trials studying Substance Abuse
2,381 Patients Enrolled for Substance Abuse
Ohio State UniversityLead Sponsor
827 Previous Clinical Trials
502,302 Total Patients Enrolled
4 Trials studying Substance Abuse
630 Patients Enrolled for Substance Abuse
National Institute on Drug Abuse (NIDA)NIH
2,464 Previous Clinical Trials
2,618,144 Total Patients Enrolled
153 Trials studying Substance Abuse
707,142 Patients Enrolled for Substance Abuse
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.I am over 18 and have been diagnosed with HIV.
Research Study Groups:
This trial has the following groups:- Group 1: Training, Feedback, Consultation, and Facilitation
- Group 2: Training, Feedback, Consultation, Facilitation, and P4P
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger